David George Joins NetGenics as Director of Customer Strategy and Consulting.CLEVELAND--(BW HealthWire)--June 29, 1999-- NetGenics, Inc. has announced the appointment of David G. George, Ph.D., as Director of Customer Strategy and Consulting. In this position, Dr. George, a recognized leader in computational biology Not to be confused with Biologically-inspired computing. Computational biology is an interdisciplinary field that applies the techniques of computer science, applied mathematics, and statistics to address problems inspired by biology. , will work closely with both customers and NetGenics' software and domain experts to translate customers' needs into creative technical solutions. "With nearly 20 years experience designing and developing informatics systems for biological research, David represents a significant enhancement to NetGenics' consultative service offering," said Manuel J. Glynias, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of NetGenics. "Through a combination of consulting services and software, NetGenics offers the practical expertise and technological savvy to build integrated, domain-spanning solutions for discovery informatics. As Director of Customer Strategy and Consulting, David will ensure that these core competencies are parlayed into the creation of solutions that address the unique challenges of our customers." Prior to joining NetGenics, Dr. George was Principal Scientist for genomic sequence data mining in the Applied Genomics applied genomics Molecular genetics Molecular medicine The use of genetic information to diagnose, prognosticate and manage disease, based on the techniques of PCR, real time-PCR, DNA sequencing, and gene rearrangement studies for leukemia and lymphoma. Division at Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were Company, Princeton, NJ. There, he championed distributed-object computer technology as a means for company-wide information integration. Dr. George represented Bristol-Myers Squibb in the establishment of the Life Science Research (LSR 1. (networking) LSR - Label Switching Router. 2. (operating system) LSR - Local Shared Resources. ) Domain Task Force, an industry-wide software standardization initiative within the Object Management Group. He was one of the major advocates in the issuance of the LSR's first request for proposal in Biomolecular Sequence Analysis. Previously, at the National Biomedical Research Foundation (NBRF NBRF National Biomedical Research Foundation ) in Washington, DC, Dr. George served as a co-director of the Protein Information Resource (PIR "Parent in room." See digispeak. ) Protein Sequence Database project, the first public data repository for curated biomolecular sequence data. He developed a database management system for the PIR project that incorporates object-oriented computing principles and is still in use after 15 years. Dr. George holds a Ph.D. in Biophysics biophysics, application of various methods and principles of physical science to the study of biological problems. In physiological biophysics physical mechanisms have been used to explain such biological processes as the transmission of nerve impulses, the muscle and an M.A. in Biology from Temple University, Philadelphia, PA. He did his post-doctoral work in molecular evolution under the late Margaret Dayhoff at the NBRF. Dr. George has published more than 50 scientific articles on computational biology and on the design and management of scientific databases. He is an affiliate associate professor at George Mason University's (Fairfax, VA) Computational Science Institute and has served as an advisor to Science magazine. NetGenics, Inc., is a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. that develops and deploys information technology solutions to accelerate life science research. The company offers a range of services that includes consultative engineering services and custom development of integrated informatics solutions on NetGenics' SYNERGY software framework. NetGenics has played a prominent role in establishing distributed computing standards for life science research through its participation in the Object Management Group. NetGenics was established in June 1996 and is headquartered in Cleveland, OH. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion